SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹124 Cr | ₹97 Cr | ₹43 Cr | ₹26 Cr | ₹41 Cr |
What is the latest Total Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹41 Cr |
How is Total Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | 28.19 | |
| Mar2024 | ₹97 Cr | 125.18 | |
| Mar2023 | ₹43 Cr | 68.27 | |
| Mar2022 | ₹26 Cr | -37.54 | |
| Mar2021 | ₹41 Cr | - | |
Compare Total Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹228.5 Cr | 0.6% | 6.1% | 11.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 0.6% |
6.1% |
11.3% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses